Scorpius Holdings, Inc. (SCPX)
OTCMKTS · Delayed Price · Currency is USD
0.0011
0.00 (0.00%)
Oct 24, 2025, 3:29 PM EDT
Scorpius Holdings Revenue
Scorpius Holdings had revenue of $212.26K in the quarter ending March 31, 2025, a decrease of -93.96%. This brings the company's revenue in the last twelve months to $2.94M, down -69.81% year-over-year. In the year 2024, Scorpius Holdings had annual revenue of $6.24M, down -10.75%.
Revenue (ttm)
2.94M
Revenue Growth
-69.81%
P/S Ratio
0.02
Revenue / Employee
32.32K
Employees
91
Market Cap
67.26K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.24M | -751.82K | -10.75% |
| Dec 31, 2023 | 6.99M | 6.62M | 1,789.60% |
| Dec 31, 2022 | 370.18K | -1.74M | -82.48% |
| Dec 31, 2021 | 2.11M | -835.16K | -28.33% |
| Dec 31, 2020 | 2.95M | -101.14K | -3.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Scorpius Holdings News
- 6 months ago - Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia - GlobeNewsWire
- 6 months ago - Scorpius Holdings (SCPX) Reports FY Loss Amid $6.2M Revenue - GuruFocus
- 6 months ago - Scorpius Holdings GAAP EPS of -$13.04 - Seeking Alpha
- 6 months ago - Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining - GlobeNewsWire
- 6 months ago - Scorpius Holdings gets NYSE American delisting notice, plans to appeal - Seeking Alpha
- 6 months ago - Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal - GlobeNewsWire
- 6 months ago - NYSE American to Commence Delisting Proceedings Against Scorpius Holdings, Inc. (SCPX) - Business Wire
- 8 months ago - Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives - GlobeNewsWire